Matches in Wikidata for { <http://www.wikidata.org/entity/Q92638605> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q92638605 description "article scientifique publié en 2020" @default.
- Q92638605 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92638605 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92638605 description "scientific article published on 13 January 2020" @default.
- Q92638605 description "wetenschappelijk artikel" @default.
- Q92638605 description "наукова стаття, опублікована 13 січня 2020" @default.
- Q92638605 name "Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature" @default.
- Q92638605 name "Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature" @default.
- Q92638605 type Item @default.
- Q92638605 label "Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature" @default.
- Q92638605 label "Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature" @default.
- Q92638605 prefLabel "Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature" @default.
- Q92638605 prefLabel "Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature" @default.
- Q92638605 P1433 Q92638605-E4FC118E-ADDB-4280-9424-30243FEB9F11 @default.
- Q92638605 P1476 Q92638605-9040D147-BD57-4F3A-936C-2467000740D4 @default.
- Q92638605 P2093 Q92638605-32E39768-C789-42D0-B68D-3F8FE06EB973 @default.
- Q92638605 P2093 Q92638605-3689BD43-E48D-4D1E-BB5A-5287098A0DA4 @default.
- Q92638605 P2093 Q92638605-3B77293A-72D0-4C00-A5DD-7528D0EC4BE2 @default.
- Q92638605 P2093 Q92638605-4F14C5CF-16E4-40A1-BCE0-51516A196A7F @default.
- Q92638605 P2093 Q92638605-4F85E98F-6720-4F31-AD33-FE789CA3E6CB @default.
- Q92638605 P2093 Q92638605-50437467-3E2C-40AB-8BD1-5655380F37D4 @default.
- Q92638605 P2093 Q92638605-6944765B-0394-4342-BD97-1F2FB7B661A7 @default.
- Q92638605 P2093 Q92638605-88E48481-4722-4220-B777-03D58FD1F93E @default.
- Q92638605 P2093 Q92638605-8F9031C3-D313-4AB6-9DF4-1A5B85E377E0 @default.
- Q92638605 P2093 Q92638605-9BA33DE2-E97F-4642-8C1A-B5BEC5DBF9E5 @default.
- Q92638605 P2093 Q92638605-B7D54FCD-D59A-4F2B-9264-743268061060 @default.
- Q92638605 P2093 Q92638605-E1E3AB4B-22ED-40E0-8F19-67E4F627E9D8 @default.
- Q92638605 P2093 Q92638605-E9E2799D-395D-4120-9CA4-CB1E27E381DA @default.
- Q92638605 P2093 Q92638605-F455B7E7-302F-4429-AD51-0C20E2D30651 @default.
- Q92638605 P2093 Q92638605-F956E532-DA9B-41DB-B873-450A3B5EC648 @default.
- Q92638605 P275 Q92638605-1273bfac-25ff-4c24-ac03-eda911c087a2 @default.
- Q92638605 P304 Q92638605-9DAB0B2F-5571-4D27-AAD8-88361F112C48 @default.
- Q92638605 P31 Q92638605-00B28EB5-8721-4BD3-841B-5ACF71B543E4 @default.
- Q92638605 P356 Q92638605-BBFE6FD2-2908-4556-A7B9-0C43221C8694 @default.
- Q92638605 P433 Q92638605-9209386D-F829-44FA-88FF-1162A049097A @default.
- Q92638605 P478 Q92638605-06291F87-D5EC-45C3-97A3-B67C272B7C1E @default.
- Q92638605 P50 Q92638605-165D17AB-D81E-4585-AB48-68157442F3B1 @default.
- Q92638605 P577 Q92638605-DBECE71B-9B32-4A8E-A2B1-83A8F5F27EBB @default.
- Q92638605 P6216 Q92638605-b866a366-6d71-4a74-bdff-e6fa44c242ea @default.
- Q92638605 P698 Q92638605-0B0F7E61-D0A6-41D3-AB15-3ACFCB3FCDD7 @default.
- Q92638605 P921 Q92638605-E0F15E08-B0B4-415C-B8A5-9878EF51B7EF @default.
- Q92638605 P356 AIUA.2019.4.205 @default.
- Q92638605 P698 31937082 @default.
- Q92638605 P1433 Q26842438 @default.
- Q92638605 P1476 "Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature" @default.
- Q92638605 P2093 "Alessandro Antonelli" @default.
- Q92638605 P2093 "Andrea Minervini" @default.
- Q92638605 P2093 "Angelo Porreca" @default.
- Q92638605 P2093 "Antonio Celia" @default.
- Q92638605 P2093 "Benjamin I Chung" @default.
- Q92638605 P2093 "Bernardo Rocco" @default.
- Q92638605 P2093 "Daniele D'Agostino" @default.
- Q92638605 P2093 "Daniele Romagnoli" @default.
- Q92638605 P2093 "Ettore De Berardinis" @default.
- Q92638605 P2093 "Francesco Del Giudice" @default.
- Q92638605 P2093 "Gian Maria Busetto" @default.
- Q92638605 P2093 "Jae Heon Kim" @default.
- Q92638605 P2093 "Luca Cindolo" @default.
- Q92638605 P2093 "Martina Maggi" @default.
- Q92638605 P2093 "Riccardo Schiavina" @default.
- Q92638605 P275 Q34179348 @default.
- Q92638605 P304 "205-210" @default.
- Q92638605 P31 Q13442814 @default.
- Q92638605 P356 "10.4081/AIUA.2019.4.205" @default.
- Q92638605 P433 "4" @default.
- Q92638605 P478 "91" @default.
- Q92638605 P50 Q38360651 @default.
- Q92638605 P577 "2020-01-13T00:00:00Z" @default.
- Q92638605 P6216 Q50423863 @default.
- Q92638605 P698 "31937082" @default.
- Q92638605 P921 Q506659 @default.